NEW YORK / RankWire.AI / – U.S. equities closed higher on Wednesday, buoyed by a significant drop in long-term Treasury yields, which supported Wall Street’s recovery. The S&P 500 increased by 16.22 points, or 0.21%, finishing at 7,707.98. The Dow Jones Industrial Average advanced 119.65 points, or 0.22%, to close at 53,463.05. Meanwhile, the Nasdaq Composite rose 41.38 points, or 0.16%, ending the day at 26,331.09. These gains halted a three-day losing streak across all three major U.S. indices.
Much of the session’s momentum was driven by developments in the bond market following the U.S. Treasury Department’s announcement regarding increased liquidity buybacks for longer-dated debt. Starting September 9, the maximum purchase size per operation will be raised to at least $4 billion from the previous $2 billion. This adjustment applies to nominal coupon securities within the 10-to-20-year and 20-to-30-year maturity ranges. The Treasury stated that these larger purchase volumes will continue through November 4 and are a response to the robust demand for high-quality offerings.
Following the announcement, Treasury yields declined as bond prices moved upward. The benchmark 10-year yield fell to approximately 4.65%, while the 30-year yield decreased to around 5.20%. On Tuesday, the 30-year yield had risen to 5.337%, reaching its highest point since 2007. The decline in yields alleviated some pressure from higher borrowing costs, which had previously weighed on equities, and contributed to Wall Street’s recovery from earlier weekly losses.
Healthcare Sector Boosts Market Sentiment
Shares in healthcare companies gained momentum after Moderna and Merck reported encouraging late-stage trial results for melanoma. Moderna’s stock surged 177%, while Merck’s shares increased by 12.6% during trading. The Phase 3 INTerpath-001 trial assessed the combination of intismeran autogene with Keytruda following surgery for patients with high-risk melanoma. The trial successfully met its primary endpoint of recurrence-free survival and also achieved a key secondary endpoint measuring survival without cancer spreading to distant sites.
Gains were also seen in consumer stocks after several major corporations announced quarterly earnings. Estée Lauder’s shares jumped over 16% after releasing its earnings report. Target and Lowe’s experienced upward movement following their latest financial disclosures. Smaller-cap stocks outperformed the large-cap indexes, with the Russell 2000 increasing roughly 0.5%. These movements contributed to broadening the market’s recovery beyond the healthcare sector. Tech stocks showed mixed performance, which limited the overall gains in the major indices.
Weekly Losses Persist Despite Wednesday’s Rally
Despite the positive close on Wednesday, the main U.S. stock indices remained lower for the week. The S&P 500 was roughly 1% below its level from the previous Friday, while the Dow had declined about 0.5%. The Nasdaq was down approximately 1.5%. The rebound was driven by a decline in long-term yields, which had previously pressured stock valuations and prompted a more cautious approach among investors across key sectors.
By the close on Wednesday, the major averages remained firmly positive for 2026. The S&P 500 had gained approximately 12.6% since the start of the year. The Dow increased about 11.2%, and the Nasdaq was up around 13.3%. The session marked a modest recovery for Wall Street, supported by falling Treasury yields and significant healthcare sector advances. Among the key market drivers during the day were the U.S. Treasury Department’s buyback announcement and the positive melanoma trial results, which helped lift investor confidence.